Dachaigh › Cancer briste triple-negative › New Mexico

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an New Mexico

Tha 3 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann an New Mexico.

Bailtean ann an New Mexico

Albuquerque3 sgrùdaidhean

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

New Mexico Oncology Hematology Consultants Ltd. ( Site 0019), Albuquerque

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

New Mexico Oncology Hematology Consultants Ltd. ( Site 0090), Albuquerque
CHRISTUS St. Vincent Regional Cancer Center ( Site 0118), Santa Fe

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06393374

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

University of New Mexico, Albuquerque
San Juan Oncology Associates, Farmington

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.